Urologic surgery often takes place within confined anatomy where tissue mobility, scar formation, prior treatment and urinary exposure can complicate the operative environment.
Evologics offers human tissue formats for clinician-directed wound coverage and selected soft-tissue reconstruction across robotic, laparoscopic and open urologic workflows.
EvoPatch is a continuous, double-layer human amniotic membrane allograft intended for use as a wound covering.
It may be considered at selected surgical sites in prostatectomy, urethral reconstruction, stricture procedures, fistula-repair environments and other pelvic operations when consistent with the current Instructions for Use.
The omni-directional design eliminates a required up-or-down orientation during placement.
A-MATRX supplies dry amniotic membrane in precision-cut micrografts.
Its geometry may be useful for focused placement around irregular surfaces, narrow tissue planes and confined reconstructive sites where a continuous membrane sheet is not preferred.
Fascia lata and pericardial allografts provide additional soft-tissue options for selected urologic reconstruction.
Use depends on the product’s processing, dimensions, mechanical characteristics, labeling and the surgeon’s specific reconstructive plan.
EvoDerm may also be evaluated for selected pelvic or soft-tissue reconstruction procedures where human dermal matrix is appropriate.
Product discussions may include:
Evologics coordinates product information, controlled documents, tissue tracking, facility review, staff education and ordering workflows.
Product information, specifications, IFUs, evidence and facility needs.
Value-analysis support, regulatory documentation, pricing and product comparison.
Ordering workflow, onboarding, staff education and initial coordination.
Clinical education, representative support, replenishment and follow-up.
Procedure examples are provided for general informational and navigation purposes. They do not establish a product indication, treatment recommendation or expected clinical outcome.
Product selection, preparation, placement and documentation remain the responsibility of the qualified healthcare professional and facility. Use must be consistent with the current Instructions for Use, product labeling, institutional policy and applicable regulatory requirements.
Where website language differs from a controlled product document, the current controlled document governs.
Request information or arrange a specialty portfolio review.